New drug ABBV-547 put to the test in healthy volunteers
NCT ID NCT07232004
First seen Nov 17, 2025 · Last updated May 14, 2026 · Updated 22 times
Summary
This early-stage study is testing a new drug, ABBV-547, in healthy adults to see if it is safe and how the body handles it. About 87 participants in the US and Japan will receive a single dose of the drug or a placebo. The study will monitor side effects and measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Acpru /Id# 278638
RECRUITINGGrayslake, Illinois, 60030, United States
-
CenExel ACT- Anaheim Clinical Trials /ID# 279612
RECRUITINGAnaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.